Skip to main content

Table 2 Epidemiological and clinical characteristics comparing IATM versus MS group

From: Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series

  IATM MS p
  group group  
N (%) 74 (87) 11 (13)  
Age, mean (SD), y 45 (16) 28.2 (9.1) 0.001 a
Sex, male/female 36/38 4/7 0.529
Follow up, median (IQR), y 2.9 (0.9–3.9) 9.9 (2.7–17.8) <0.001 a
Time to maximum deficit, mean (SD), d 6.9 (7.2) 8.5 (7) 0.487
Admission Rankin, Mean (SD) 2.8 (1.2) 2.45 (1.1) 0.284
Outcome Rankin Mean (SD) 1.3 (1.3) 1.8 (1.2) 0.290
Time onset-start treatment, mean (SD), d 9 (8.1) 2 (2.2) 0.553
Back pain, n (%) 30 (40.5) 5 (45.5) 0.755
Urinary sphincter dysfunction, n (%) 41 (55.4) 6 (54.5) 0.603
Anal sphincter dysfunction, n (%) 10 (13.5) 1 (9.1) 0.566
Previous infection, n (%) 23 (31.1) 4 (36.4) 0.485
Summer season/Not summer season, n (%) 13/72(18.1)/59/72 (81.9) 1/11 (9.1)/10/11 (90.9) 0.460
TM relapses, n (%) 0/73 (0) 5/11 (45.5) <0.001 a
  1. IATM: Idiopathic acute transverse myelitis.
  2. MS: Multiple Sclerosis.
  3. IQR: Interquartile range.
  4. SD: Standard deviation.
  5. TM: Transverse myelitis.
  6. aSignificant after Bonferroni correction.